Fredag 13 November | 10:16:15 Europe / Stockholm
Est. tid*
2028-01-25 08:00 Bokslutskommuniké 2027
2027-10-19 08:00 Kvartalsrapport 2027-Q3
2027-07-16 08:00 Kvartalsrapport 2027-Q2
2027-04-20 N/A Årsstämma
2027-04-20 08:00 Kvartalsrapport 2027-Q1
2027-01-26 08:00 Bokslutskommuniké 2026
2026-10-21 - Kvartalsrapport 2026-Q3
2026-07-17 - Kvartalsrapport 2026-Q2
2026-04-22 - X-dag ordinarie utdelning GETI B 4.75 SEK
2026-04-21 - Årsstämma
2026-04-21 - Kvartalsrapport 2026-Q1
2026-01-27 - Bokslutskommuniké 2025
2025-10-21 - Kvartalsrapport 2025-Q3
2025-07-18 - Kvartalsrapport 2025-Q2
2025-04-23 - X-dag ordinarie utdelning GETI B 4.60 SEK
2025-04-22 - Årsstämma
2025-04-22 - Kvartalsrapport 2025-Q1
2025-01-28 - Bokslutskommuniké 2024
2024-10-18 - Kvartalsrapport 2024-Q3
2024-07-18 - Kvartalsrapport 2024-Q2
2024-04-23 - X-dag ordinarie utdelning GETI B 4.40 SEK
2024-04-22 - Årsstämma
2024-04-22 - Kvartalsrapport 2024-Q1
2024-02-01 - Bokslutskommuniké 2023
2023-10-23 - Kvartalsrapport 2023-Q3
2023-07-18 - Kvartalsrapport 2023-Q2
2023-04-27 - X-dag ordinarie utdelning GETI B 4.25 SEK
2023-04-26 - Årsstämma
2023-04-26 - Kvartalsrapport 2023-Q1
2023-02-01 - Bokslutskommuniké 2022
2022-10-19 - Kvartalsrapport 2022-Q3
2022-07-19 - Kvartalsrapport 2022-Q2
2022-04-27 - X-dag ordinarie utdelning GETI B 4.00 SEK
2022-04-26 - Årsstämma
2022-04-26 - Kvartalsrapport 2022-Q1
2022-01-28 - Bokslutskommuniké 2021
2021-10-20 - Kvartalsrapport 2021-Q3
2021-07-16 - Kvartalsrapport 2021-Q2
2021-04-21 - X-dag ordinarie utdelning GETI B 3.00 SEK
2021-04-20 - Årsstämma
2021-04-20 - Kvartalsrapport 2021-Q1
2021-01-28 - Bokslutskommuniké 2020
2020-10-16 - Kvartalsrapport 2020-Q3
2020-07-16 - Kvartalsrapport 2020-Q2
2020-06-29 - X-dag ordinarie utdelning GETI B 1.50 SEK
2020-06-26 - Årsstämma
2020-04-22 - Kvartalsrapport 2020-Q1
2020-01-30 - Bokslutskommuniké 2019
2019-10-18 - Kvartalsrapport 2019-Q3
2019-07-17 - Kvartalsrapport 2019-Q2
2019-04-24 - X-dag ordinarie utdelning GETI B 1.00 SEK
2019-04-23 - Årsstämma
2019-04-23 - Kvartalsrapport 2019-Q1
2019-01-30 - Bokslutskommuniké 2018
2018-10-18 - Kvartalsrapport 2018-Q3
2018-07-17 - Kvartalsrapport 2018-Q2
2018-04-27 - X-dag ordinarie utdelning GETI B 1.50 SEK
2018-04-26 - Årsstämma
2018-04-26 - Kvartalsrapport 2018-Q1
2018-01-29 - Bokslutskommuniké 2017
2017-10-18 - Kvartalsrapport 2017-Q3
2017-07-17 - Kvartalsrapport 2017-Q2
2017-04-25 - Kvartalsrapport 2017-Q1
2017-03-30 - X-dag ordinarie utdelning GETI B 2.00 SEK
2017-03-29 - Årsstämma
2017-01-26 - Bokslutskommuniké 2016
2016-10-18 - Kvartalsrapport 2016-Q3
2016-07-14 - Kvartalsrapport 2016-Q2
2016-04-22 - Kvartalsrapport 2016-Q1
2016-03-31 - X-dag ordinarie utdelning
2016-03-30 - Årsstämma
2016-01-28 - Bokslutskommuniké 2015
2015-10-15 - Kvartalsrapport 2015-Q3
2015-09-02 - Extra Bolagsstämma 2015
2015-07-15 - Kvartalsrapport 2015-Q2
2015-04-20 - Kvartalsrapport 2015-Q1
2015-03-26 - X-dag ordinarie utdelning GETI B 2.80 SEK
2015-03-25 - Årsstämma
2015-01-28 - Bokslutskommuniké 2014
2014-10-16 - Analytiker möte 2014
2014-10-16 - Kvartalsrapport 2014-Q3
2014-07-15 - Kvartalsrapport 2014-Q2
2014-04-16 - Kvartalsrapport 2014-Q1
2014-03-21 - X-dag ordinarie utdelning GETI B 4.15 SEK
2014-03-20 - Årsstämma
2014-01-28 - Bokslutskommuniké 2013
2013-10-15 - 15-7 2013
2013-10-15 - Analytiker möte 2013
2013-10-15 - Kvartalsrapport 2013-Q3
2013-07-11 - Kvartalsrapport 2013-Q2
2013-04-17 - Kvartalsrapport 2013-Q1
2013-03-22 - X-dag ordinarie utdelning GETI B 4.15 SEK
2013-03-21 - Årsstämma
2013-02-08 - Kapitalmarknadsdag 2013
2013-01-25 - Bokslutskommuniké 2012
2012-10-17 - Analytiker möte 2012
2012-10-17 - Kvartalsrapport 2012-Q3
2012-07-11 - Kvartalsrapport 2012-Q2
2012-04-19 - Kvartalsrapport 2012-Q1
2012-03-29 - X-dag ordinarie utdelning GETI B 3.75 SEK
2012-03-28 - Årsstämma
2012-01-26 - Bokslutskommuniké 2011
2011-10-20 - Kvartalsrapport 2011-Q3
2011-07-11 - Kvartalsrapport 2011-Q2
2011-04-28 - X-dag ordinarie utdelning GETI B 3.25 SEK
2011-04-27 - Årsstämma
2011-04-27 - Kvartalsrapport 2011-Q1
2011-01-28 - Kapitalmarknadsdag 2011
2011-01-26 - Bokslutskommuniké 2010
2010-10-19 - Kvartalsrapport 2010-Q3
2010-04-23 - X-dag ordinarie utdelning GETI B 2.75 SEK
2010-04-22 - X-dag ordinarie utdelning GETI B 2.75 SEK
2010-04-21 - Årsstämma
2010-04-21 - Kvartalsrapport 2010-Q1
2010-01-26 - Bokslutskommuniké 2009
2009-07-13 - Kvartalsrapport 2009-Q2
2009-05-06 - Kvartalsrapport 2009-Q3
2009-04-22 - X-dag ordinarie utdelning GETI B 2.40 SEK
2009-04-21 - Årsstämma
2009-04-21 - Kvartalsrapport 2009-Q1
2008-04-18 - X-dag ordinarie utdelning GETI B 2.40 SEK
2007-04-20 - X-dag ordinarie utdelning GETI B 2.20 SEK
2006-04-21 - X-dag ordinarie utdelning GETI B 2.00 SEK
2005-04-20 - X-dag ordinarie utdelning GETI B 1.65 SEK
2004-04-22 - X-dag ordinarie utdelning GETI B 1.35 SEK
2003-11-25 - Split GETI B 1:4
2003-04-24 - X-dag ordinarie utdelning GETI B 4.25 SEK
2002-04-19 - X-dag ordinarie utdelning GETI B 3.75 SEK
2001-04-24 - X-dag ordinarie utdelning GETI B 3.50 SEK
2000-04-28 - X-dag ordinarie utdelning GETI B 3.50 SEK
1999-04-22 - X-dag ordinarie utdelning GETI B 3.25 SEK
1998-04-24 - X-dag ordinarie utdelning GETI B 2.75 SEK
1997-04-30 - X-dag ordinarie utdelning GETI B 2.50 SEK
1996-04-19 - X-dag ordinarie utdelning GETI B 6.00 SEK
LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Getinge är ett globalt medicintekniskt bolag som specialiserar sig på att tillhandahålla utrustning och IT-system till hälso- och sjukvården samt life science-industrin. Bolaget erbjuder bland annat lösningar för operationssalar, intensivvårdsavdelningar, steriliseringscentraler och läkemedelsutveckling. Bolaget grundades 1904 och har sitt huvudkontor i Göteborg.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Getinge establishes Sustainable Financing Framework

2026-11-12 12:30:00

Getinge has established a Sustainable Financing Framework, which sets out the principles and criteria for the medtech company's green or social sustainability financing of eligible projects with environmental and/or social benefits. The framework has been independently reviewed by Sustainable Fitch, which rated its Use of Proceeds, Project Evaluation and Selection, and Reporting and Transparency as "Excellent", and Management of Proceeds as "Good". Svenska Handelsbanken AB (publ) (SHB) acted as the structuring advisor in the development of the framework.

The framework links Getinge's financing activities with its sustainability strategy and sets out the criteria for how proceeds from sustainable debt instruments may be used. Eligible projects span both social and environmental areas, with a particular focus on access to essential healthcare services, alongside energy efficiency, pollution- and emission prevention and control, and sustainable water and wastewater management. With the healthcare sector accounting for approximately 5% of global emissions[1], reducing its environmental footprint while making efficient use of limited resources is increasingly important.

"For us, sustainability is about taking a holistic view of healthcare. It is not only about environmental and social impact, but also about how we use resources to support the best possible outcomes for patients. More resource-efficient healthcare can benefit patients, healthcare systems and the environment, and this framework gives us another way to connect financing with those priorities," says Anna Romberg, EVP Sustainability, Legal & Compliance at Getinge.

Under the social financing category, proceeds can be used to finance or refinance projects that increase and improve the quality, accessibility and patient experience of essential healthcare services. This includes solutions for intensive care and surgical workflows, organ transplant care, cardiovascular care, and life science. Getinge expects approximately 80-90% of proceeds to be allocated to projects related to access to essential healthcare services.

The green financing categories cover investments in energy efficiency, pollution prevention and control, and sustainable water and wastewater management. These include, for example, initiatives to reduce energy and water consumption, improve resource and material efficiency, reduce waste, and develop more resource-efficient products and processes.

The framework has been developed in alignment with the 2025 ICMA Green Bond Principles and Social Bond Principles, the ICMA Sustainability Bond Guidelines, as well as relevant green and social loan principles.

The Sustainable Financing Framework and Sustainable Fitch's Second-Party Opinion are available on Getinge's website >>

Investor relations:
David Kördel, Head of Investor Relations
Phone: +46(0)10 335 0077
Email: david.kordel@getinge.com

Media relations:
Caroline Örmgård, Head of Media Relations
Phone: +46 (0)10 335 0041
Email: caroline.ormgard@getinge.com

About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.

[1] https://www.who.int/publications/i/item/9789240118423